摘要
目的探讨阿奇霉素对生物被膜(BF)阳性铜绿假单胞菌(PA)Ⅰ类整合酶基因(intI1)mRNA表达量的影响。方法对某院临床分离的10株PA进行intI1基因检测,选择其中1株BF+intI1基因阳性的PA进行培养,并设空白对照组和阿奇霉素处理组(按阿奇霉素浓度不同分为3个浓度组,分别为16、32、64 mg/L组),重复试验5次,采用荧光定量聚合酶链式反应(RT-PCR)检测其intI1 mRNA的表达情况。结果16 mg/L阿奇霉素组、32 mg/L阿奇霉素组、64 mg/L阿奇霉素组和对照组intI1 mRNA相对表达量分别为(1.15±0.04)、(12.47±3.10)、(19.71±0.78)和(1.00±0.00),各组间比较,差异有统计学意义(F=163.82,P<0.001);组间两两比较,除低浓度阿奇霉素组(16 mg/L)与对照组比较,差异无统计学意义(P>0.05)外,其他各组间比较,差异均有统计学意义(P<0.05),阿奇霉素组intI1 mRNA表达量随培养液中阿奇霉素浓度升高而升高。结论在阿奇霉素压力下BF阳性的PA,intI1表达有所上调,可提高耐药基因的捕获概率,促进耐药基因重组。
Objective To evaluate the effect of azithromycin on class Ⅰ integron-integrase gene (intI 1 )mRNA expression in biofilm-forming (BF)Pseudomonas aeruginosa (PA).Methods intI 1 of 10 PA strains isolated from a hospital were detected,1 strain with positive BF+intI 1 was selected for culture,blank control group and three az-ithromycin trial groups (divided according to 3 concentrations:16 mg/L,32 mg/L,and 64 mg/L)were set,experi-ments were repeated 5 times,expression of intI 1 mRNA were detected by RT-PCR.Results Relative expression of intI 1 mRNA in azithromycin groups of 16 mg/L,32 mg/L,64 mg/L,and control group were (1 .15 ±0.04), (12.47±3.10),(19.71 ±0.78 ),and (1 .00 ±0.00),respectively,there were significant difference among four groups(F =163.82,P 〈0.001 );intI 1 mRNA expression between 16mg/L azithromycin group and control group was not significantly different (P 〉0.05),but among other groups were significantly different (P 〈0.05 ),intI 1 mRNA expression in azithromycin groups increased with the enhancing concentration of azithromycin in culture so-lution .Conclusion Expression of intI 1 gene mRNA in BF PA can be up-regulated by the present of azithromycin, which may improve the probability of drug-resistant genes,and promote drug-resistant gene recombination.
出处
《中国感染控制杂志》
CAS
北大核心
2015年第9期597-600,共4页
Chinese Journal of Infection Control
基金
福建省卫生厅青年基金(2012-2-41)
中华医院感染控制研究基金(ZHYG2014-0010)
关键词
铜绿假单胞菌
生物被膜
Ⅰ类整合酶
阿奇霉素
抗药性
微生物
抗菌药物
Pseudomonas aeruginosa
biofilm
class I integron-integrase gene
azithromycin
drug resistance, microbial
antimicrobial agent